NO984740L - Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler - Google Patents
Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midlerInfo
- Publication number
- NO984740L NO984740L NO984740A NO984740A NO984740L NO 984740 L NO984740 L NO 984740L NO 984740 A NO984740 A NO 984740A NO 984740 A NO984740 A NO 984740A NO 984740 L NO984740 L NO 984740L
- Authority
- NO
- Norway
- Prior art keywords
- analgesics
- compounds
- acetylcholinesterase inhibitors
- isatin derivatives
- isatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63187096A | 1996-04-12 | 1996-04-12 | |
PCT/US1997/003598 WO1997038993A1 (en) | 1996-04-12 | 1997-03-07 | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984740L true NO984740L (no) | 1998-10-09 |
NO984740D0 NO984740D0 (no) | 1998-10-09 |
Family
ID=24533114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984740A NO984740D0 (no) | 1996-04-12 | 1998-10-09 | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0892796B1 (da) |
JP (1) | JP4109718B2 (da) |
KR (1) | KR20000005379A (da) |
CN (1) | CN1215399A (da) |
AR (1) | AR006606A1 (da) |
AT (1) | ATE207483T1 (da) |
BR (1) | BR9708655A (da) |
CA (1) | CA2252039C (da) |
DE (1) | DE69707659T2 (da) |
DK (1) | DK0892796T3 (da) |
ES (1) | ES2165586T3 (da) |
GR (1) | GR3037006T3 (da) |
HU (1) | HUP9903473A3 (da) |
IL (1) | IL126308A0 (da) |
NO (1) | NO984740D0 (da) |
PT (1) | PT892796E (da) |
TW (1) | TW426678B (da) |
WO (1) | WO1997038993A1 (da) |
ZA (1) | ZA972990B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
IN2012DN06631A (da) | 2010-02-16 | 2015-10-23 | Pfizer | |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2789440C (en) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
MX362886B (es) | 2012-12-13 | 2019-02-22 | H Lundbeck As | Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva. |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US10537552B2 (en) | 2015-05-05 | 2020-01-21 | Carafe Drug Innovation, Llc | Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994472A (en) * | 1989-08-02 | 1991-02-19 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-(pyridinylamino)-2-pyrrolidinones as pain relievers |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
US5296488A (en) * | 1989-08-02 | 1994-03-22 | Hoechst-Roussel Pharmaceuticals Inc. | Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory |
-
1997
- 1997-03-07 DE DE69707659T patent/DE69707659T2/de not_active Expired - Fee Related
- 1997-03-07 EP EP97908942A patent/EP0892796B1/en not_active Expired - Lifetime
- 1997-03-07 BR BR9708655A patent/BR9708655A/pt not_active Application Discontinuation
- 1997-03-07 JP JP53708497A patent/JP4109718B2/ja not_active Expired - Fee Related
- 1997-03-07 IL IL12630897A patent/IL126308A0/xx unknown
- 1997-03-07 WO PCT/US1997/003598 patent/WO1997038993A1/en active IP Right Grant
- 1997-03-07 HU HU9903473A patent/HUP9903473A3/hu unknown
- 1997-03-07 PT PT97908942T patent/PT892796E/pt unknown
- 1997-03-07 ES ES97908942T patent/ES2165586T3/es not_active Expired - Lifetime
- 1997-03-07 CN CN97193728A patent/CN1215399A/zh active Pending
- 1997-03-07 CA CA002252039A patent/CA2252039C/en not_active Expired - Fee Related
- 1997-03-07 DK DK97908942T patent/DK0892796T3/da active
- 1997-03-07 AT AT97908942T patent/ATE207483T1/de not_active IP Right Cessation
- 1997-04-07 TW TW086104363A patent/TW426678B/zh active
- 1997-04-08 ZA ZA9702990A patent/ZA972990B/xx unknown
- 1997-04-11 AR ARP970101447A patent/AR006606A1/es unknown
-
1998
- 1998-10-09 NO NO984740A patent/NO984740D0/no unknown
- 1998-10-12 KR KR1019980708105A patent/KR20000005379A/ko active IP Right Grant
-
2001
- 2001-10-25 GR GR20010401584T patent/GR3037006T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW426678B (en) | 2001-03-21 |
IL126308A0 (en) | 1999-05-09 |
PT892796E (pt) | 2002-03-28 |
ES2165586T3 (es) | 2002-03-16 |
ZA972990B (en) | 1997-11-03 |
ATE207483T1 (de) | 2001-11-15 |
KR20000005379A (en) | 2000-01-25 |
HUP9903473A2 (hu) | 2000-05-28 |
NO984740D0 (no) | 1998-10-09 |
AU716997B2 (en) | 2000-03-16 |
BR9708655A (pt) | 1999-08-03 |
AR006606A1 (es) | 1999-09-08 |
CA2252039C (en) | 2002-12-24 |
WO1997038993A1 (en) | 1997-10-23 |
CA2252039A1 (en) | 1997-10-23 |
DE69707659D1 (de) | 2001-11-29 |
JP2001508400A (ja) | 2001-06-26 |
DK0892796T3 (da) | 2001-11-19 |
HUP9903473A3 (en) | 2000-09-28 |
JP4109718B2 (ja) | 2008-07-02 |
EP0892796B1 (en) | 2001-10-24 |
CN1215399A (zh) | 1999-04-28 |
GR3037006T3 (en) | 2002-01-31 |
EP0892796A1 (en) | 1999-01-27 |
AU2072597A (en) | 1997-11-07 |
DE69707659T2 (de) | 2002-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984740L (no) | Isatinderivater som acetylcholinesteraseinhibitorer og analgetiske midler | |
MX9702865A (es) | Agentes estrogenicos. | |
AP9701039A0 (en) | Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one. | |
BG106340A (en) | Substituted oxoazaheterocyclyl compounds | |
WO2002046170A8 (en) | Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
MY112413A (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
AU2019502A (en) | Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto | |
NO20005714L (no) | Nye substituerte cykliske forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
BR0007589A (pt) | Inibidores da proliferação de células | |
NZ312840A (en) | Ketoheterocyclic inhibitors of factor Xa | |
RU94036448A (ru) | Производные галантамина и фармацевтическая композиция | |
NO996108L (no) | 9-oksinerytromycinderivater | |
NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
EA200101077A1 (ru) | Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его | |
NO984470L (no) | Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase | |
NO990896L (no) | Bidentate metalloproteaseinhibitorer | |
EG20726A (en) | Process for preparing of galanthamine derivatives as acetylchol inc-sterase inhibitors | |
WO2001072708A3 (en) | OXINDOLE INHIBITORS OF FACTOR Xa | |
PT1044186E (pt) | Composto 2-benzilamino-2-fenil-acetamida substituidos | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
WO2001081316A3 (en) | Substituted phenyl farnesyltransferase inhibitors | |
NO975681L (no) | Benzisoxazol- og indazol-derivater som antipsykotiske midler | |
NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
NO983444D0 (no) | Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer |